Short answer: a fully disclosed label — every ingredient with its exact per-serving amount — lets you actually evaluate a formula against published research. A proprietary blend hides that comparison entirely, regardless of how impressive the ingredient list looks.
Why proprietary blends make evaluation impossible
When a label lists a "joint support blend" totaling 500mg across six ingredients without individual amounts, you can't know whether any single ingredient is present at a dose that matches published research — it could be 400mg of one compound and a trace amount of the rest. Full disclosure removes that ambiguity entirely.
What "backed by published research citations" honestly means
Citing sources like WebMD or the NCCIH for an individual ingredient (like glucosamine or boswellia) tells you that ingredient has a research base — it does not mean the finished, multi-ingredient product has been through its own clinical trial. A transparent brand distinguishes between these two claims rather than blurring them.
What "best transparent label" should actually mean in 2026
- Every ingredient named individually — with its own milligram amount, not folded into a blend total
- Sourced citations for individual ingredients — ideally linking to recognizable, checkable sources
- Clear acknowledgment that ingredient-level research isn't the same as finished-product proof
A practical checklist for reading any joint supplement label
- Is every ingredient listed with its own specific amount?
- Do stated amounts roughly match doses used in the cited research?
- Does the brand distinguish ingredient-level evidence from product-level proof?
- Is there a genuine refund window if the claims don't hold up for you personally?
See all ten disclosed JointBrex ingredients and amounts
No proprietary blend, every dose stated.
See the Full Ingredient List